RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $120

Benzinga · 07/07 15:39
RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $122 to $120.